Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-024550
Filing Date
2025-03-17
Accepted
2025-03-17 16:15:19
Documents
74
Period of Report
2025-01-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0234387-10q_enzobio.htm   iXBRL 10-Q 748909
2 CERTIFICATION ea023438701ex31-1_enzobio.htm EX-31.1 10464
3 CERTIFICATION ea023438701ex31-2_enzobio.htm EX-31.2 10575
4 CERTIFICATION ea023438701ex32-1_enzobio.htm EX-32.1 3681
5 CERTIFICATION ea023438701ex32-2_enzobio.htm EX-32.2 3337
  Complete submission text file 0001213900-25-024550.txt   5344533

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE enz-20250131.xsd EX-101.SCH 40135
7 XBRL CALCULATION FILE enz-20250131_cal.xml EX-101.CAL 54243
8 XBRL DEFINITION FILE enz-20250131_def.xml EX-101.DEF 235355
9 XBRL LABEL FILE enz-20250131_lab.xml EX-101.LAB 446391
10 XBRL PRESENTATION FILE enz-20250131_pre.xml EX-101.PRE 254306
76 EXTRACTED XBRL INSTANCE DOCUMENT ea0234387-10q_enzobio_htm.xml XML 695567
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 25744607
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)